ARCHIVES

An Adult Surgery Adapted To Children Increased Survival Of Rare Abdominal Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 5 | May 28, 2010

Download PDF Visit The Full Archive

Related Articles

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

In Brief: Senate approves $13.69 Billion for NIH, House To Act This Week; Amounts Are Close

September 19, 1997

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977